Literature DB >> 12208949

The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction.

Jennifer L Bromberg-White1, Craig Meyers.   

Abstract

The upstream regulatory region (URR) of various types of human papillomaviruses (HPVs) has been shown to contain functional glucocorticoid response elements (GREs), including HPV type 11 (HPV11), HPV16, and HPV18. Glucocorticoids have been demonstrated to induce the transcriptional activity of the early promoters of these HPV types. Although it has been assumed that the URR of HPV31 contains at least one GRE, no functionality has been demonstrated. We attempt to show here inducibility of the URR of HPV31 by the synthetic glucocorticoid dexamethasone (dex). By sequence analysis we identified three potential GREs in the URR of HPV31. Gel shift analysis indicated that each of these three sites has the potential to be a functional GRE. However, constructs containing the full-length URR, 5' deletions of the URR, and an internal fragment of the URR containing all three putative GREs were only weakly inducible by dex. Linker scanning mutants, whereby each potential GRE was replaced individually, in double combination, or in triple combination by a unique polylinker, had no effect on dex inducibility. Replacement of each of the three HPV31 GREs with the GRE of HPV18 failed to induce a response to dex. Placement of the HPV18 GRE into the URR of HPV31 in a region similar to its location in the HPV18 URR was also unable to result in a strong dex induction of the HPV31 URR. These data suggest that the lack of dex inducibility is due to the overall context of the HPV31 URR and may be dependent on the requirements of the major early promoter for transcriptional activation. Finally, replacement of the HPV18 GRE with each of the HPV31 GREs in HPV18 only showed weak inducibility, indicating that the three GREs of HPV31 are in fact only weak inducers of dex. Overall, these data suggest that dex responsiveness, along with oncogenic potential, may provide a possible explanation for the classification of HPV31 as an intermediate-risk virus and demonstrate the complexity of transcriptional regulation of the URR of HPV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208949      PMCID: PMC136493          DOI: 10.1128/jvi.76.19.9702-9715.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.

Authors:  C Meyers; M G Frattini; J B Hudson; L A Laimins
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

2.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes.

Authors:  M Hummel; J B Hudson; L A Laimins
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b.

Authors:  M A Ozbun; C Meyers
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  Effect of glucocorticoid hormone on nuclear matrix in cervical cancer cells in vitro.

Authors:  H F Yam; Z H Wang; P C Or; S W Wang; J Li; E C Chew
Journal:  Anticancer Res       Date:  1998 Jan-Feb       Impact factor: 2.480

5.  A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells.

Authors:  S Mader; J H White
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

6.  Evidence for the separate regulation of the human papillomavirus type 11 E7 and E6 promoters by Viral cis sequences near the E6 promoter.

Authors:  T P DiLorenzo; D Chen; P Zhang; B M Steinberg
Journal:  Virology       Date:  1998-03-30       Impact factor: 3.616

7.  DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5' of the minimal origin.

Authors:  W G Hubert; T Kanaya; L A Laimins
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions.

Authors:  R Mittal; A Pater; M M Pater
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

Authors: 
Journal:  Int J Cancer       Date:  1993-09-09       Impact factor: 7.396

10.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.

Authors:  A T Lorincz; R Reid; A B Jenson; M D Greenberg; W Lancaster; R J Kurman
Journal:  Obstet Gynecol       Date:  1992-03       Impact factor: 7.661

View more
  3 in total

1.  Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter.

Authors:  Jason M Bodily; Craig Meyers
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

2.  Induction of the upstream regulatory region of human papillomavirus type 31 by dexamethasone is differentiation dependent.

Authors:  Jennifer L Bromberg-White; Ellora Sen; Samina Alam; Jason M Bodily; Craig Meyers
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

3.  Genetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.

Authors:  Ellora Sen; Samina Alam; Craig Meyers
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.